Severe generalized junctional epidermolysis bullosa Advocacy Hub | UniteRare

At a Glance

Live from database

💊

1FDA treatments

💰

2Open funds

Regulatory Watchboard

No FDA or trial events recorded yet for Severe generalized junctional epidermolysis bullosa.

Financial Assistance

2 programs

FINANCIAL LANDSCAPE SUMMARY

Total programs

Open now

Patient Assistance Programs2

Duraclon

Roxane Laboratories, Inc.

OpenContact for details

CNJ-016

Cangene Corporation

OpenContact for details

View all support programs on disease page →

Approved Treatments

1 FDA-approved

Duraclon

(Clonidine)Orphan drugstandard

Roxane Laboratories, Inc.

Mechanism of Action Epidurally administered clonidine produces dose-dependent analgesia not antagonized by opiate antagonists. The analgesia is limite...

FDA label ↗

View full treatment details on disease page →

Clinical Trial Landscape

No active clinical trials currently recruiting for Severe generalized junctional epidermolysis bullosa.
Search all trials →

Search clinical trials for Severe generalized junctional epidermolysis bullosa →

Recent News & Research

No recent news articles indexed yet for Severe generalized junctional epidermolysis bullosa.
Search PubMed for Severe generalized junctional epidermolysis bullosa →

Browse all Severe generalized junctional epidermolysis bullosa news →

Specialist Network

No specialists currently listed for Severe generalized junctional epidermolysis bullosa.

View all Severe generalized junctional epidermolysis bullosa specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰